BioCentury
ARTICLE | Clinical News

Azor: Preliminary Phase IV data

May 10, 2010 7:00 AM UTC

Preliminary data from the open-label, single-arm, dose-titration, U.S. Phase IV BP CRUSH trial in 999 patients with uncontrolled hypertension on monotherapy and who switched to Azor without a washout ...